Rocket Pharmaceuticals
RCKT • NASDAQ
Rocket Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gaurav D. Shah, with a market cap of $399.4M.
Market Cap$399.4M
Employees268.0
CEOGaurav D. Shah
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Rocket Pharmaceuticals FAQ
Common questions about Rocket Pharmaceuticals
Rocket Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 14, 2026 before market open. Analysts estimate revenue of $4.5M.
Rocket Pharmaceuticals has approximately 268 employees.